KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $25.3 million.

  • Zimmer Biomet Holdings' Share-based Compensation rose 326.53% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $87.2 million, marking a year-over-year decrease of 1711.03%. This contributed to the annual value of $101.0 million for FY2024, which is 120.24% up from last year.
  • Zimmer Biomet Holdings' Share-based Compensation amounted to $25.3 million in Q3 2025, which was up 326.53% from $21.2 million recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' Share-based Compensation ranged from a high of $33.9 million in Q2 2023 and a low of $14.9 million during Q4 2021
  • In the last 5 years, Zimmer Biomet Holdings' Share-based Compensation had a median value of $24.5 million in 2024 and averaged $23.6 million.
  • In the last 5 years, Zimmer Biomet Holdings' Share-based Compensation surged by 7986.58% in 2022 and then plummeted by 4306.57% in 2023.
  • Zimmer Biomet Holdings' Share-based Compensation (Quarter) stood at $14.9 million in 2021, then soared by 79.87% to $26.8 million in 2022, then decreased by 5.6% to $25.3 million in 2023, then dropped by 16.6% to $21.1 million in 2024, then increased by 19.91% to $25.3 million in 2025.
  • Its last three reported values are $25.3 million in Q3 2025, $21.2 million for Q2 2025, and $19.6 million during Q1 2025.